ストックスクリーナーアプリを入手
1.92
5.49%
0.10
アフターアワーズ：
1.91
-0.01
-0.52%
前日終値:
$1.82
開ける：
$1.8
24時間の取引高:
2.08M
Relative Volume:
0.78
時価総額：
$202.17M
収益：
-
当期純損益:
$-37.34M
株価収益率:
-1.4118
EPS:
-1.36
ネットキャッシュフロー:
$-36.91M
1週間 パフォーマンス:
+3.78%
1か月 パフォーマンス:
+6.67%
6か月 パフォーマンス:
+68.42%
1年 パフォーマンス:
+42.22%
1日の値動き範囲:
$1.79
$1.97
1週間の範囲:
$1.75
$1.97
52週間の値動き範囲:
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
名前
Sellas Life Sciences Group Inc
セクター
電話
(646) 200-5278
住所
7 TIMES SQUARE, NEW YORK, NY
SLS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.92 | 191.64M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-11-01 | 開始されました | Oppenheimer | Outperform |
| 2018-04-02 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-19 | アップグレード | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc (SLS) 最新ニュース
Can technical indicators confirm SELLAS Life Sciences Group Inc.’s reversalWatch List & Fast Gaining Stock Strategy Reports - Newser
Can trapped investors hope for a rebound in SAIHWSell Signal & Daily Growth Stock Tips - Newser
Sector ETF performance correlation with SELLAS Life Sciences Group Inc.2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Live market analysis of SELLAS Life Sciences Group Inc.Sell Signal & Technical Analysis for Trade Confirmation - Newser
How to track smart money flows in SELLAS Life Sciences Group Inc.July 2025 Momentum & Technical Pattern Based Signals - Newser
Price action breakdown for SELLAS Life Sciences Group Inc.Earnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Can a trend reversal in SELLAS Life Sciences Group Inc. lead to recovery2025 Momentum Check & Safe Investment Capital Preservation Plans - Newser
Is SELLAS Life Sciences Group Inc. forming a bottoming baseQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Is NNAGW stock ready for a breakoutForecast Cut & Fast Entry High Yield Tips - Newser
How high can Docebo Inc. stock goMarket Trend Report & Fast Momentum Stock Entry Tips - Newser
Does SELLAS Life Sciences Group Inc. qualify in momentum factor screeningJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
Is SELLAS Life Sciences Group Inc. stock reversal real or fakeJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
RSI Divergence May Trigger a Bounce in SELLAS Life Sciences Group Inc.Quarterly Market Summary & Step-by-Step Trade Execution Guides - kangso.co.kr
Is SELLAS Life Sciences Group Inc. a candidate for recovery playTrade Exit Summary & Capital Efficient Trading Techniques - Newser
SELLAS Life Sciences Group Inc. stock daily chart insightsQuarterly Investment Review & Safe Entry Momentum Tips - Newser
What is SELLAS Life Sciences Group Inc.’s book value per shareJuly 2025 Final Week & Accurate Entry/Exit Alerts - theviewers.co.kr
How to forecast SELLAS Life Sciences Group Inc. trends using time seriesWeekly Gains Report & Weekly Market Pulse Alerts - Newser
Has SELLAS Life Sciences Group Inc. formed a bullish divergenceJuly 2025 Technicals & Daily Stock Momentum Reports - Newser
Should value investors consider SELLAS Life Sciences Group Inc.Earnings Summary Report & Proven Capital Preservation Methods - theviewers.co.kr
SELLAS Life Sciences Group Inc. Stock Poised for Technical Comeback2025 Price Action Summary & Daily Oversold Stock Bounce Ideas - 더경남뉴스
SELLAS Life Sciences’ Triumphant Advances - StocksToTrade
Resistance Break Could Fuel SELLAS Life Sciences Group Inc. RallyJuly 2025 Chart Watch & Free Fast Entry Momentum Trade Alerts - beatles.ru
Sellas Life Sciences: SLS009’s Phase 2 Sets Up A Promising 2026 (NASDAQ:SLS) - Seeking Alpha
What risks could impact SELLAS Life Sciences Group Inc. stock performanceInsider Buying & Stepwise Trade Signal Guides - Newser
SELLAS Life Sciences Rises On Cancer Trial Progress And New Listings - Finimize
What’s the fair value of SELLAS Life Sciences Group Inc. stockEarnings Recap Summary & Low Drawdown Momentum Ideas - mustnews.co.kr
Published on: 2025-08-15 06:21:10 - beatles.ru
Chart Patterns Forming a Bullish Setup in SELLAS Life Sciences Group Inc.2025 Technical Patterns & Real-Time Volume Trigger Notifications - beatles.ru
Optimistic Buy Rating for SELLAS Life Sciences Group Driven by Promising Trial Results and Financial Stability - TipRanks
Sellas Life Sciences Reports Q2 2025 Financial Results - TipRanks
Sellas Life Sciences Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Sellas Life Sciences' GPS Trial Continues with Positive IDMC Recommendation - AInvest
SELLAS Life Sciences Receives Positive IDMC Recommendation to Continue Phase 3 REGAL Trial of GPS in AML. - AInvest
Sellas Life Sciences Group Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 Regal Trial of GPS in AML Without Modification - MarketScreener
SELLAS Life Sciences Gets Positive IDMC Nod To Continue Phase 3 Trial Of AML Treatment - Nasdaq
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification - The Manila Times
IDMC recommends continuation of Phase 3 AML trial for galinpepimut-S - Investing.com India
SELLAS Life Sciences Announces Independent Data Monitoring - GlobeNewswire
SELLAS Phase 3 Cancer Drug GPS Clears Critical Safety Review, Final Data Expected This Year - Stock Titan
SELLAS Life Sciences Group Inc. Consolidation Zone May Signal AccumulationMulti-Bagger Potential Stock Forecast Tools Released - metal.it
What institutional investors are buying SELLAS Life Sciences Group Inc. stockGet alerts on top growth stocks daily - Jammu Links News
What analysts say about SELLAS Life Sciences Group Inc. stockDiscover investment plans that deliver results - Jammu Links News
What is the risk reward ratio of investing in SELLAS Life Sciences Group Inc. stockBuild a portfolio for long-term financial success - Jammu Links News
Does SELLAS Life Sciences Group Inc. stock perform well during market downturnsExceptional profit velocity - Jammu Links News
How does SELLAS Life Sciences Group Inc. compare to its industry peersBreakout stock performance - Jammu Links News
What are the latest earnings results for SELLAS Life Sciences Group Inc.Achieve fast wealth growth with smart picks - Jammu Links News
What are analysts’ price targets for SELLAS Life Sciences Group Inc. in the next 12 monthsRapid profit acceleration - Jammu Links News
What makes SELLAS Life Sciences Group Inc. stock price move sharplyGet professional advice for portfolio optimization - Jammu Links News
What are SELLAS Life Sciences Group Inc. company’s key revenue driversInvest smarter with daily stock recommendations - Jammu Links News
Sellas Life Sciences Group Inc (SLS) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):